AVTR Avantor, Inc.
NYSE · SEC CIK 1722482 · EDGAR
- Bought, last 12 months
- $8.69M 8 purchases by 5 insiders
- Sold, last 12 months
- $0 0 sales by 0 insiders
- Filings on record
- 272 since 2021-07-13, latest 2026-09-23 16:30
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| MEHRA SANJEEV K | Dir | $4.88M | — |
| SUMME GREGORY L | Dir | $2.06M | — |
| Ligner Emmanuel | Pres, CEO, Dir | $993.1K | — |
| LUCIER GREGORY T | Dir | $541.2K | — |
| Dingemans Simon | Dir | $203.5K | — |
| Brellier Ludovic | EVP, Bioscience, Medtech | — | — |
| Blenn Mary | EVP, COO | — | — |
| Makin Louise | Dir | — | — |
| Gourdier Benoit | EVP, Bioscience, Medtech | — | — |
| Hankamer Brittany | EVP, Chief HR Off | — | — |
Transactions 328
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-02-27 | 2023-02-24 | AVTR | Vanderhaegen Frederic | EVP, Americas, Europe | A - Grant | $0.00 | +20.3K | 188.2K | +12% | $0 |
| D | 2023-02-27 | 2023-02-24 | AVTR | Bramwell James | EVP, Americas | A - Grant | $0.00 | +20.3K | 104.8K | +24% | $0 |
| DM | 2023-02-27 | 2023-02-23+ | AVTR | Bramwell James | EVP, Americas | F - Tax | $24.60 | -1,080 | 104.3K | -1% | -$26.6K |
| DM | 2023-02-27 | 2023-02-23+ | AVTR | Henson Meghan | EVP, Chief HR Off | F - Tax | $24.60 | -1,616 | 40.2K | -4% | -$39.8K |
| D | 2023-02-27 | 2023-02-24 | AVTR | Henson Meghan | EVP, Chief HR Off | A - Grant | $0.00 | +12.2K | 41.0K | +42% | $0 |
| 2023-02-22 | 2023-02-20 | AVTR | Szlosek Thomas A | EVP, CFO | F - Tax | $24.54 | -4,253 | 90.9K | -4% | -$104.4K | |
| 2023-02-22 | 2023-02-20 | AVTR | Stubblefield Michael | Pres, CEO, Dir | F - Tax | $24.54 | -15.0K | 1.20M | -1% | -$368.7K | |
| 2023-02-22 | 2023-02-20 | AVTR | Eck Steven W | SVP, CAO | F - Tax | $24.54 | -435 | 17.3K | -2% | -$10.7K | |
| 2023-02-22 | 2023-02-22 | AVTR | Couturier Christophe | EVP, AMEA | S - Sale | $24.12 | -19.2K | 97.2K | -16% | -$462.1K | |
| 2023-02-22 | 2023-02-20 | AVTR | Couturier Christophe | EVP, AMEA | F - Tax | $24.54 | -1,167 | 117.0K | -1.0% | -$28.6K | |
| 2023-02-22 | 2023-02-20 | AVTR | Brophy Gerard | EVP, Biopharma Production | F - Tax | $24.54 | -3,072 | 99.3K | -3% | -$75.4K | |
| 2023-02-22 | 2023-02-20 | AVTR | Miller Justin | EVP, GC | F - Tax | $24.54 | -1,167 | 97.7K | -1% | -$28.6K | |
| 2023-02-22 | 2023-02-20 | AVTR | Bramwell James | EVP, Americas | F - Tax | $24.54 | -1,066 | 85.1K | -1% | -$26.2K | |
| 2023-02-22 | 2023-02-20 | AVTR | Vanderhaegen Frederic | EVP, Americas, Europe | F - Tax | $24.54 | -398 | 168.1K | -0.2% | -$9,767 | |
| 2023-02-22 | 2023-02-20 | AVTR | Wondrasch Michael | EVP, CIO | F - Tax | $24.54 | -1,356 | 96.1K | -1% | -$33.3K | |
| 2023-02-02 | 2023-01-31 | AVTR | Couturier Christophe | EVP, AMEA | F - Tax | $23.90 | -7,658 | 118.2K | -6% | -$183.0K | |
| 2023-02-02 | 2023-01-31 | AVTR | Couturier Christophe | EVP, AMEA | A - Grant | $0.00 | +26.8K | 125.8K | +27% | $0 | |
| 2023-02-02 | 2023-01-31 | AVTR | Miller Justin | EVP, GC | A - Grant | $0.00 | +26.8K | 106.8K | +34% | $0 | |
| 2023-02-02 | 2023-01-31 | AVTR | Miller Justin | EVP, GC | F - Tax | $23.90 | -7,942 | 98.8K | -7% | -$189.8K | |
| 2023-02-02 | 2023-01-31 | AVTR | Stubblefield Michael | CEO, Dir | F - Tax | $23.90 | -91.1K | 1.21M | -7% | -$2.18M | |
| 2023-02-02 | 2023-01-31 | AVTR | Stubblefield Michael | CEO, Dir | A - Grant | $0.00 | +223.5K | 1.30M | +21% | $0 | |
| 2023-02-02 | 2023-01-31 | AVTR | Vanderhaegen Frederic | EVP, Americas, Europe | F - Tax | $23.90 | -2,515 | 168.5K | -1% | -$60.1K | |
| 2023-02-02 | 2023-01-31 | AVTR | Vanderhaegen Frederic | EVP, Americas, Europe | A - Grant | $0.00 | +44.7K | 171.1K | +35% | $0 | |
| 2023-02-02 | 2023-01-31 | AVTR | Brophy Gerard | EVP, Biopharma Production | F - Tax | $23.90 | -15.2K | 113.7K | -12% | -$363.8K | |
| 2023-02-02 | 2023-02-02 | AVTR | Brophy Gerard | EVP, Biopharma Production | S - Sale | $25.06 | -11.3K | 102.4K | -10% | -$284.2K | |
| 2023-02-02 | 2023-01-31 | AVTR | Brophy Gerard | EVP, Biopharma Production | A - Grant | $0.00 | +38.7K | 128.9K | +43% | $0 | |
| 2023-02-02 | 2023-01-31 | AVTR | Szlosek Thomas A | EVP, CFO | F - Tax | $23.90 | -24.2K | 124.6K | -16% | -$578.1K | |
| 2023-02-02 | 2023-01-31 | AVTR | Szlosek Thomas A | EVP, CFO | A - Grant | $0.00 | +53.6K | 148.8K | +56% | $0 | |
| 2023-01-04 | 2022-12-31 | AVTR | Lewis Sheri | EVP, Gbl Ops, Supply Chain | F - Tax | $21.09 | -6,075 | 65.4K | -9% | -$128.1K | |
| 2023-01-04 | 2023-01-02 | AVTR | Vanderhaegen Frederic | EVP, Americas, Europe | F - Tax | $21.09 | -1,017 | 126.4K | -0.8% | -$21.4K | |
| 2023-01-04 | 2023-01-02 | AVTR | Szlosek Thomas A | EVP, CFO | F - Tax | $21.09 | -8,313 | 109.4K | -7% | -$175.3K | |
| 2023-01-04 | 2023-01-02 | AVTR | Brophy Gerard | EVP, Biopharma Production | F - Tax | $21.09 | -6,727 | 90.2K | -7% | -$141.9K | |
| 2023-01-04 | 2022-12-31 | AVTR | Henson Meghan | EVP, Chief HR Off | F - Tax | $21.09 | -1,790 | 29.6K | -6% | -$37.8K | |
| I | 2022-11-17 | 2022-11-16 | AVTR | Szlosek Thomas A | EVP, CFO | P - Purchase | $20.71 | +12.5K | 35.7K | +54% | +$258.9K |
| I | 2022-11-17 | 2022-11-16 | AVTR | Stubblefield Michael | CEO, Dir | P - Purchase | $20.95 | +15.0K | 429.5K | +4% | +$314.2K |
| 2022-05-23 | 2022-05-20 | AVTR | Brophy Gerard | EVP, Biopharma Production | S - Sale | $31.27 | -19.6K | 96.9K | -17% | -$613.0K | |
| 2022-05-23 | 2022-05-23 | AVTR | Vanderhaegen Frederic | EVP, Americas, Europe | S - Sale | $31.61 | -39.0K | 126.8K | -24% | -$1.23M | |
| 2022-05-19 | 2022-05-17 | AVTR | Couturier Christophe | EVP, AMEA | F - Tax | $31.33 | -16.2K | 98.3K | -14% | -$507.9K | |
| 2022-05-19 | 2022-05-17 | AVTR | Vanderhaegen Frederic | EVP, Americas, Europe | F - Tax | $31.33 | -2,210 | 165.8K | -1% | -$69.2K | |
| 2022-05-19 | 2022-05-17 | AVTR | Miller Justin | EVP, GC | F - Tax | $31.33 | -12.9K | 79.3K | -14% | -$405.3K | |
| 2022-05-19 | 2022-05-17 | AVTR | Brophy Gerard | EVP, Biopharma Production | F - Tax | $31.33 | -19.7K | 116.5K | -14% | -$616.7K | |
| 2022-05-19 | 2022-05-17 | AVTR | Stubblefield Michael | Pres, CEO, Dir | F - Tax | $31.33 | -108.7K | 1.19M | -8% | -$3.41M | |
| 2022-05-19 | 2022-05-17 | AVTR | Szlosek Thomas A | EVP, CFO | F - Tax | $31.33 | -23.3K | 140.3K | -14% | -$728.8K | |
| 2022-05-19 | 2022-05-17 | AVTR | Eck Steven W | SVP, CAO | F - Tax | $31.33 | -573 | 17.7K | -3% | -$18.0K | |
| 2022-05-16 | 2022-05-12 | AVTR | Peacock Jonathan M | Dir | A - Grant | $0.00 | +6,693 | 176.3K | +4% | $0 | |
| 2022-05-16 | 2022-05-12 | AVTR | Andres Juan | Dir | A - Grant | $0.00 | +6,693 | 30.1K | +29% | $0 | |
| 2022-05-16 | 2022-05-12 | AVTR | Holt Matthew S. | Dir | A - Grant | $0.00 | +6,693 | 7,908 | +551% | $0 | |
| 2022-05-16 | 2022-05-12 | AVTR | Shaw Christi | Dir | A - Grant | $0.00 | +6,693 | 26.5K | +34% | $0 | |
| 2022-05-16 | 2022-05-12 | AVTR | SUMME GREGORY L | Dir | A - Grant | $0.00 | +6,693 | 22.7K | +42% | $0 | |
| 2022-05-16 | 2022-05-12 | AVTR | Murthy Mala | Dir | A - Grant | $0.00 | +6,693 | 8,824 | +314% | $0 | |
| 2022-05-16 | 2022-05-12 | AVTR | Carethers John | Dir | A - Grant | $0.00 | +6,693 | 10.5K | +177% | $0 | |
| 2022-05-16 | 2022-05-12 | AVTR | SEVERINO MICHAEL | Dir | A - Grant | $0.00 | +6,693 | 25.2K | +36% | $0 | |
| 2022-05-16 | 2022-05-12 | AVTR | Kang Lan | Dir | A - Grant | $0.00 | +6,693 | 11.9K | +128% | $0 | |
| 2022-05-16 | 2022-05-12 | AVTR | Massaro Joseph R | Dir | A - Grant | $0.00 | +6,693 | 8,653 | +341% | $0 | |
| 2022-05-06 | 2022-05-04 | AVTR | Stubblefield Michael | Pres, CEO, Dir | G - Gift | $0.00 | -14.5K | 1.30M | -1% | $0 | |
| I | 2022-05-06 | 2022-05-04 | AVTR | Stubblefield Michael | Pres, CEO, Dir | G - Gift | $0.00 | +14.5K | 414.5K | +4% | $0 |
| 2022-04-07 | 2022-04-05 | AVTR | Couturier Christophe | EVP, AMEA | F - Tax | $31.62 | -568 | 114.6K | -0.5% | -$18.0K | |
| 2022-04-05 | 2022-04-01 | AVTR | Holt Matthew S. | Dir | A - Grant | $0.00 | +1,215 | 1,215 | New | $0 | |
| 2022-04-05 | 2022-04-01 | AVTR | SUMME GREGORY L | Dir | A - Grant | $0.00 | +1,215 | 16.0K | +8% | $0 | |
| 2022-04-05 | 2022-04-01 | AVTR | Murthy Mala | Dir | A - Grant | $0.00 | +1,215 | 2,131 | +133% | $0 | |
| 2022-04-05 | 2022-04-01 | AVTR | Massaro Joseph R | Dir | A - Grant | $0.00 | +1,215 | 1,960 | +163% | $0 | |
| 2022-04-05 | 2022-04-01 | AVTR | Shaw Christi | Dir | A - Grant | $0.00 | +1,215 | 19.8K | +7% | $0 | |
| 2022-04-05 | 2022-04-01 | AVTR | Andres Juan | Dir | A - Grant | $0.00 | +1,215 | 23.4K | +5% | $0 | |
| 2022-04-05 | 2022-04-01 | AVTR | Kang Lan | Dir | A - Grant | $0.00 | +1,215 | 5,237 | +30% | $0 | |
| 2022-04-05 | 2022-04-01 | AVTR | Carethers John | Dir | A - Grant | $0.00 | +1,215 | 3,780 | +47% | $0 | |
| 2022-04-05 | 2022-04-01 | AVTR | Peacock Jonathan M | Dir | A - Grant | $0.00 | +1,215 | 169.6K | +0.7% | $0 | |
| 2022-04-05 | 2022-04-01 | AVTR | SEVERINO MICHAEL | Dir | A - Grant | $0.00 | +1,215 | 18.5K | +7% | $0 | |
| 2022-04-05 | 2022-04-01 | AVTR | GUPTA RAJIV | Dir | A - Grant | $0.00 | +1,215 | 780.6K | +0.2% | $0 | |
| 2022-03-02 | 2022-03-01 | AVTR | Brophy Gerard | EVP, Biopharma Production | S - Sale | $34.47 | -2,027 | 136.2K | -1% | -$69.9K | |
| D | 2022-02-25 | 2022-02-25 | AVTR | Couturier Christophe | EVP, AMEA | F - Tax | $35.39 | -467 | 115.1K | -0.4% | -$16.5K |
| D | 2022-02-25 | 2022-02-23 | AVTR | Couturier Christophe | EVP, AMEA | A - Grant | $0.00 | +6,044 | 115.6K | +6% | $0 |
| D | 2022-02-25 | 2022-02-25 | AVTR | Brophy Gerard | EVP, Biopharma Production | F - Tax | $35.39 | -2,043 | 138.2K | -1% | -$72.3K |
| D | 2022-02-25 | 2022-02-23 | AVTR | Brophy Gerard | EVP, Biopharma Production | A - Grant | $0.00 | +15.1K | 140.3K | +12% | $0 |
| D | 2022-02-25 | 2022-02-23 | AVTR | Brophy Gerard | EVP, Biopharma Production | S - Sale | $33.79 | -3,059 | 125.2K | -2% | -$103.4K |
| D | 2022-02-25 | 2022-02-25 | AVTR | Stubblefield Michael | CEO, Dir | F - Tax | $35.39 | -7,866 | 1.31M | -0.6% | -$278.4K |
| D | 2022-02-25 | 2022-02-23 | AVTR | Stubblefield Michael | CEO, Dir | A - Grant | $0.00 | +69.9K | 1.32M | +6% | $0 |
| D | 2022-02-25 | 2022-02-23 | AVTR | Vanderhaegen Frederic | EVP, Americas, Europe | A - Grant | $0.00 | +15.1K | 168.2K | +10% | $0 |
| D | 2022-02-25 | 2022-02-25 | AVTR | Vanderhaegen Frederic | EVP, Americas, Europe | F - Tax | $35.39 | -216 | 168.0K | -0.1% | -$7,644 |
| D | 2022-02-25 | 2022-02-25 | AVTR | Eck Steven W | SVP, CAO | F - Tax | $35.39 | -518 | 18.3K | -3% | -$18.3K |
| D | 2022-02-25 | 2022-02-23 | AVTR | Eck Steven W | SVP, CAO | A - Grant | $0.00 | +5,138 | 18.8K | +38% | $0 |
| D | 2022-02-25 | 2022-02-23 | AVTR | Lewis Sheri | EVP, Gbl Ops, Supply Chain | A - Grant | $0.00 | +9,822 | 72.6K | +16% | $0 |
| D | 2022-02-25 | 2022-02-25 | AVTR | Lewis Sheri | EVP, Gbl Ops, Supply Chain | F - Tax | $35.39 | -1,137 | 71.4K | -2% | -$40.2K |
| D | 2022-02-25 | 2022-02-25 | AVTR | Szlosek Thomas A | EVP, CFO | F - Tax | $35.39 | -2,043 | 252.7K | -0.8% | -$72.3K |
| D | 2022-02-25 | 2022-02-23 | AVTR | Szlosek Thomas A | EVP, CFO | A - Grant | $0.00 | +16.6K | 254.8K | +7% | $0 |
| D | 2022-02-25 | 2022-02-23 | AVTR | Miller Justin | EVP, GC | A - Grant | $0.00 | +6,800 | 92.8K | +8% | $0 |
| D | 2022-02-25 | 2022-02-25 | AVTR | Miller Justin | EVP, GC | F - Tax | $35.39 | -583 | 92.2K | -0.6% | -$20.6K |
| D | 2022-02-25 | 2022-02-23 | AVTR | Henson Meghan | EVP, Chief HR Off | A - Grant | $0.00 | +8,311 | 32.3K | +35% | $0 |
| D | 2022-02-25 | 2022-02-25 | AVTR | Henson Meghan | EVP, Chief HR Off | F - Tax | $35.39 | -931 | 31.4K | -3% | -$32.9K |
| 2022-02-22 | 2022-02-20 | AVTR | Stubblefield Michael | Pres, CEO, Dir | F - Tax | $34.00 | -11.0K | 1.25M | -0.9% | -$372.6K | |
| 2022-02-22 | 2022-02-20 | AVTR | Eck Steven W | SVP, CAO | F - Tax | $34.00 | -448 | 13.7K | -3% | -$15.2K | |
| 2022-02-22 | 2022-02-20 | AVTR | Miller Justin | EVP, GC | F - Tax | $34.00 | -1,328 | 86.0K | -2% | -$45.2K | |
| 2022-02-22 | 2022-02-20 | AVTR | Szlosek Thomas A | EVP, CFO | F - Tax | $34.00 | -4,040 | 238.2K | -2% | -$137.4K | |
| 2022-02-22 | 2022-02-20 | AVTR | Couturier Christophe | EVP, AMEA | F - Tax | $34.00 | -1,267 | 109.6K | -1% | -$43.1K | |
| 2022-02-22 | 2022-02-20 | AVTR | Vanderhaegen Frederic | EVP, Europe | F - Tax | $28.69 | -398 | 153.1K | -0.3% | -$11.4K | |
| 2022-02-22 | 2022-02-20 | AVTR | Brophy Gerard | EVP, Biopharma Production | F - Tax | $34.00 | -3,072 | 128.2K | -2% | -$104.4K | |
| 2022-01-18 | 2022-01-13 | AVTR | Murray Mark Christopher | EVP, Biomaterials, AT | F - Tax | $37.50 | -918 | 18.7K | -5% | -$34.4K | |
| 2022-01-05 | 2022-01-02 | AVTR | Szlosek Thomas A | EVP, CFO | F - Tax | $42.14 | -8,101 | 242.2K | -3% | -$341.4K | |
| 2022-01-05 | 2022-01-02 | AVTR | Wondrasch Michael | EVP, CIO | F - Tax | $42.14 | -9,517 | 104.3K | -8% | -$401.0K | |
| D | 2022-01-05 | 2022-01-02 | AVTR | Brophy Gerard | EVP, Biopharma Production | F - Tax | $42.14 | -6,516 | 142.9K | -4% | -$274.6K |
| DM | 2022-01-05 | 2022-01-03+ | AVTR | Brophy Gerard | EVP, Biopharma Production | S - Sale+OE | $40.42 | -71.0K | 142.9K | -33% | -$2.87M |
Purchase Sale Sale after option exercise All abbreviations